birtamimab
prothena
['birtamimab']
#ash22 ends tomorrow and today is the last day of smid-cap biopharma presentations! $prta presenting survival data from ph3 vital study today from birtamimab trial in al amyloidosis see full #ash table in our blog: $xbi $ibb #biotech
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanr11i